Home
Attorneys
Practice Areas
Securities Litigation
Healthcare Litigation
Shareholder and Board Actions
Commodities
Bankruptcy
Commercial Litigation
Results Achieved
News
Cases in Court
Announcements
Publications and Media Interviews
Career Opportunities
Contact Us
Results Achieved
Securities Litigation
$79.75 million recovery for class of United States investors in Philip Services Corp. securities
$100 million recovery for manipulation of natural gas commodity markets
$78.7 million recovery for major municipal pension funds which invested in WorldCom securities
$27.25 million for shareholder class of purchasers of CINAR securities
Won rights for U.S. shareholders to sue foreign companies who sell securities in the U.S. for Class of investors in Philip Services Corp. securities
$22.8 million for class of holders of MBNA credit cards
$106 million recovery for class of shareholders of Reliance Acceptance Group Inc.
Healthcare Litigation
Dismissal of class action lawsuit for Aetna, Inc.
$80 million class settlement for class of end-payers, led by our clients, Wisconsin BC/BS and Aetna, which puchased Cardizem CD
Won allocation of 82% of a $44 million Warfarin Sodium settlement for class of third party payers
Favorable (but confidential) Opt Out Settlement for TPPs which Purchased Augmentin including Humana, CIGNA, Aetna and United Healthcare
$55 million settlement for group of health insurers that overpaid for Lupron including Humana, CIGNA and others
$28.7 million class settlement for class of consumers and third party payers who purchased Hytrin
$15 million plus settlement for group of third party payers, including Aetna and CIGNA, who purchased Relafen
Private settlement (amount confidential) for TPPs, including GM, IBM, Verizon, GE, Aetna, CIGNA, WellPoint, and others who purchased Baycol
Intervened in class action and successfully protected contractual rights to recover from Medco for our clients Verizon, CIGNA, a group of Blue Cross plans and all class members
Won federal appeals court reversal recognizing third party payer right of recovery for overpayment for defective drugs for class of third party payers led by our client Blue Cross/Blue Shield of Louisiana
Shareholder and Board Actions
Increase in share price and change in voting rights to ensure fair review of proposal for Aramark shareholder class led by UFCW Tri-State Pension Fund
Settlement gaining board seats and reimbursement of litigation expenses from Delcath Systems, Inc. following victory in emergency appeal for Laddcap Value Partners
Blocked ratification of an unfavorable new management agreement for Salomon Brothers Asset Management by winning precedent setting opinion for Karpus Investment Management
Additional compensation for class of NYSE seatholders in Archipelago Merger
$99 million of additional merger compensation for class led by our client Dolphin Limited Partners
Won appraisal award after trial of $2.43 per share more than public shareholders who did not seek appraisal for clients holding Travelocity securities including an institutional investor and an investment advisor
Incumbent director elections invalidated, new election ordered and entire board of directors of MVC Capital replaced with our clients' slate for Millennium Partners
Successful opt-out strategy in DaimlerChrysler Litigation led to highly favorable (confidential) recovery for our clients relative to class settlement for Glickenhaus & Co. and corporate affiliates